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ABSTRACT
Upon viral infection, the host’s immune system can induce the antiviral state to
protect from further infection. In this antiviral state, RNA synthesis and protein synthesis
are downregulated, and viral replication is inhibited (Kawai and Akira, 2006). Two of the
key pathways critical to establishing the antiviral state include the Toll-like receptor
(TLR) and the interferon (IFN) receptor (IFNR) pathways (Kawai and Akira, 2006). The
TLR pathway is critical to recognizing viral components, while the IFNR pathway is vital
to activating genes necessary for inducing the antiviral state. As the host evolves to
combat viral infections, viruses have also evolved to circumvent such host antiviral
immune response. One viral evasion mechanism is via disruption of cell membrane
domains known as caveolae. Caveolae membrane domains are critical to maintaining a
platform from which molecules can signal and have been implicated in a variety of
disease processes, including breast and prostate cancer, type II diabetes, and
atherosclerosis (Cohen et al., 2004).
Previous studies show that viral infection leads to a downregulation in caveolin
transcripts and the dispersal of IFNR clusters (Gabor et al., Submitted). As a result, the
host’s antiviral immune response is dampened. In the present study, I suggest a role for
caveolae in the TLR9 signaling pathway. Through Fluorescence Photoactivation
Localization Microscopy (FPALM) imaging, I observe spatial overlap, or colocalization,
of TLR9 and caveolin molecules. When caveolin is depleted, TLR9 signaling, upon
exposure to unmethylated CpG DNA, is dampened. Understanding the mechanisms by
which a pathogen may evade the host’s immune system will provide further insights into
new and effective treatments, such as IFN and TLR antiviral therapies.
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INTRODUCTION
Immunity, or the ability to resist an infection, is composed of two components:
innate immunity and adaptive immunity (Warrington et al., 2011). Innate immunity is
present in all organisms and is thus of interest for further research. Part of the innate
immune response is the induction of the antiviral state, which allows the host to block
viral replication and subsequently further infection (Kawai and Akira, 2006). Two of the
key pathways involved in establishing the antiviral state include the Toll-like receptor
(TLR) pathway and the interferon (IFN) receptor (IFNR) pathway (Kawai and Akira,
2006).
Viruses are intracellular pathogens that depend upon host cell machinery in order
to replicate and cause infection. While the host has evolved to combat viral infections,
viruses have also evolved to circumvent the host’s antiviral immune response. Currently,
there is a heavy emphasis placed on research involving viral evasion of the host’s
immune system. As a result, intracellular TLRs, such as Toll-like receptor 9 (TLR9), are
being studied extensively (Blasius and Beutler, 2010).
Many viruses have managed to disrupt the innate immune response via disruption
of IFN signaling (Kawai and Akira, 2006). Recently, our lab has found that one such way
is via modification of cell membrane domains known as caveolae. Caveolae membrane
domains have been identified in various tissues and cell types and have been implicated
in a variety of signal transduction pathways, including β-adrenergic receptors and
epidermal growth factor receptors (Cohen et al., 2004). In addition, caveolae have been
suggested to play a role in numerous disease processes, including breast and prostate
cancer, type II diabetes, and atherosclerosis (Cohen et al., 2004). Thus, these cell
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membrane domains are targets for further research. Suggesting a role for caveolae in viral
evasion of the host’s immune system will aid in developing new and effective treatments,
such as IFN and TLR antiviral therapies.

BACKGROUND
If you have the flu, also known as influenza, you will experience symptoms such
as fever, cough, congestion, aches, and fatigue. When you sneeze or cough, you cover
your nose and mouth with your hands, hoping to contain the spread of the influenza virus.
But you are actually spreading it around when you do not wash your hands, and then go
to touch a doorknob. The next person to touch that doorknob will become exposed to the
influenza virus.
Viruses are prevalent throughout the world and can cause numerous infections
and diseases. More than 90% of human illnesses may be caused by viral infections, which
are generally systemic (Norkin et al., 2009). In order to replicate and thus cause further
infection, viruses require host cell machinery (Garcia-Sastre and Biron, 2006). In healthy
cells, the host’s immune system can induce the antiviral state through the Toll-like
receptor (TLR) and the interferon (IFN) receptor (IFNR) pathways (Kawai and Akira,
2006). In this antiviral state, RNA synthesis and protein synthesis are downregulated and
thus viral replication cannot proceed (Kawai and Akira, 2006). As a result, viral infection
is blocked. Recently, our lab has found that upon viral infection, cell membrane domains
known as caveolae are modified. This allows the virus to evade the host’s antiviral state.
Caveolae are cell membrane domains that have been implicated in a variety of
signal transduction pathways, as well as numerous diseases processes, including breast
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and prostate cancer, and type II diabetes (Cohen et al., 2004). The organization of these
cell membrane domains acts as a platform for signaling molecules and is vital to proper
signaling (Cohen et al., 2004). The role of caveolae during the immune response to viral
infection is largely unexplored.
Performing such studies in the human will give rise to ethical concerns, so I
employ the zebrafish as a model for human diseases. This aquatic organism is an
established mainstream model for development, genetics, cancer, infection and immunity,
but I employ it as a model for human infectious diseases. The zebrafish offers many
advantages over other common model organisms, including the mouse (Mus musculus)
and the fruit fly (Drosophila melanogaster) (Lieschke and Currie, 2007). Advantages of
employing this organism include its small size, short generation time and reproduction
rate, optical clarity, and the possibility of in vivo real-time imaging host-pathogen
interactions (Lieschke and Currie, 2007). Like the mouse model, the zebrafish model
shares many similarities with humans. The zebrafish genome is fully sequenced and there
are numerous homologous genes (Grunwald and Eisen, 2002).
In order to visualize caveolae membrane domains in living systems, Fluorescence
Photoactivation Localization Microscopy (FPALM) is employed. Conventional light
microscopy is unable to circumvent the diffraction barrier, which reduces spatial
resolution (Gabor et al., 2011). FPALM allows imaging of structures that are under 250
nm in size, such as caveolae, that cannot otherwise be visualized via conventional
microscopy (Gabor et al., 2011).
Previous studies have shown that knockdown of caveolin-1 (Cav-1) leads to a
dampened antiviral immune response (Gabor et al., Submitted). Viral infection led to
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dampened cav-1 expression, which resulted in dampened signaling downstream of the
IFNR pathway. I hypothesize that caveolae may play an important role in the TLR
pathway. Understanding the mechanisms by which viruses are able to evade the host’s
antiviral immune response will aid in developing new and effective treatments. IFN and
TLR antiviral therapies will be aimed at boosting host immunity to viral infections.

VIRUSES
Viruses are intracellular
pathogens composed of
proteins and nucleic acids.
They are dependent upon host
cell machinery, such as
enzymes, in order to replicate
and cause further infection
(Garcia-Sastre and Biron,
2006). The replication cycle of
a virus is as follows: entry into

Fig. 1 Basic overview of viral infections in humans
(Harvey et al., 2007).

the cell, manipulation of host
cell machinery and use of own machinery to replicate its genome and proteins, and exit of
viral progeny to infect other host cells. This latter step in the cycle usually causes the
death of the host cell (Garcia-Sastre and Biron, 2006).
Viruses are prevalent throughout the world and can cause numerous infections
and diseases (Fig. 1). They have evolved ways to evade the host’s immune system so
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understanding how they do this will provide insights into other viral infections, other
human diseases, and host immunity. Targeted treatments, such as interferon (IFN) and
Toll-like receptor (TLR) antiviral therapies, will be aimed at boosting host immunity to
viral infections.

ZEBRAFISH AS A MODEL ORGANISM
Model organisms are employed in biomedical research to better understand the
pathogenesis of human diseases. In recent years, the zebrafish has been established as a
mainstream model for development, genetics, cancer, infection and immunity. In the
present study, I employ zebrafish as a model for human infectious diseases.
It was not until the late 1960s through the works of George Streisinger that the
zebrafish was employed as a model for developmental biology and genetics (Grunwald
and Eisen, 2002). The zebrafish model has been utilized to further our current
understanding of oncogenesis (Amsterdam et al., 2004), fin regeneration (Huang et al.,
2003), and bacterial infection (Herbomel et al., 1999).
Due to genome homology and similarities in anatomy and physiology, the mouse
(Mus musculus) has become a vital mammalian model organism (Lieschke and Currie,
2007). But many factors must be taken into consideration when developing such model
organisms, especially human disease models (Fig. 2). Since there is such functional
conservation in basic cellular processes in mammals and invertebrates, the disruption of
these conserved processes can be accurately modeled at a genetic and molecular level in
the fruit fly (Drosophilia melanogaster) (Lieschke and Currie, 2007). Unfortunately,
invertebrates lack many structures present in mammals so their role in modeling human
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diseases is limited (Lieschke and Currie, 2007). Furthermore, the scope of screens that
are currently performed with invertebrates cannot be duplicated in the mouse without
exhausting essential resources such as time and money. The zebrafish (Danio rerio)
provides a solution to this dilemma and serves as a viable vertebrate model system.
Some of the attributes of this model organism include external fertilization and
development, small size (3-5 cm), short generation time (2-4 months), high reproductive
rate (100-200 embryos per week) and high population density (5 fish/liter) (Meijer and
Spaink, 2011). Considerable
genomic resources exist for
zebrafish through the ongoing
sequencing of its genome, and
zebrafish have been demonstrated
to be amenable to genetic
manipulation (Lieschke and
Currie, 2007). The zebrafish also
provides potential for genomic
and large-scale mutant analyses.
Transgenesis, or the
Fig. 2 There are many advantages and disadvantages
to employing certain model organisms for human
process of introducing an
diseases. The zebrafish has been established as an
excellent model organism for human diseases
exogenous gene so the organism
(Lieschke and Currie, 2007).
will express that gene, is possible in the zebrafish. Due to temporal separation of four
weeks of innate responses from adaptive responses, innate factors involved in pathology
can be isolated and characterized (Meijer and Spaink, 2011). Perhaps most important is

7
its optical clarity. Zebrafish embryos allow living imaging of important cellular
processes, including phagocytosis (process by which pathogens are engulfed and
destroyed) and chemotaxis (Fig. 3) (Meijer and Spaink, 2011). The zebrafish affords the
ability to image in vivo in real-time the interactions between the host and the pathogen,
lending a major advantage over other models. Using differential interference contrast
(DIC) microscopy or transgenic lines with fluorescently marked immune cells and/or
pathogens, in vivo imaging of host-pathogen interactions in real-time is made possible
(Meijer and Spaink, 2011).

Fig. 3 (A) Bright-field view of 48 hour post-fertilization (hpf) zebrafish embryo. (B)
Confocal image of 48 hpf zebrafish embryo infected with green fluorescent protein
(GFP)-tagged snakehead rhabdovirus (SHRV). (C) Bright-field view of 48 hpf
zebrafish embryo infected with red fluorescent protein (RFP)-tagged bacteria ((A &
B) Courtesy of Kristin A. Gabor; (C) Singer et al., 2010).
There are many advantages to utilizing zebrafish as a model for human infectious
diseases, but as with any model organism, there are also some problems. Zebrafish must
be maintained at around 28°C, but human pathogens thrive at 37°C (Lieschke and Currie,
2007). Therefore, it might be difficult to study some pathogens at this lower temperature.
To avoid this, fish-specific pathogens could be employed, but such host-pathogen
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interactions might be attributed to pathogens that are fish-specific (Lieschke and Currie,
2007).
Due to the attributes previously mentioned, the zebrafish has emerged as an
excellent model for human infectious diseases and has been established as a model for
various infectious pathogens, such as Pseudomonas aeruginosa (Phennicie et al., 2010)
and snakehead rhabdovirus (SHRV) (Phelan et al., 2005). The zebrafish model will
continue to offer advantages that can work alongside other human disease models.
Furthering our understanding of these pathologies will not only aid in developing
effective therapies for a range of human diseases, but also providing insights into fishspecific diseases and the study of aquaculture (Lieschke and Currie, 2007).

IMMUNITY
Like the mouse, the zebrafish shares many similarities with humans. The
zebrafish genome is fully sequenced and there are numerous homologous genes
(Grunwald and Eisen, 2002). In addition, a well-developed complement system (a
pathway that recognizes and opsonizes, or coats, foreign antigens, rendering them
susceptible to phagocytosis) and conservation in inflammatory proteins have been
observed in the zebrafish (Meeker and Trede, 2008). Furthermore, there are zebrafish
homologs of most Toll-like receptors (TLR) (Meeker and Trede, 2008). As a result, the
zebrafish immune system serves as a strong model of the mammalian immune system.
Immunity is composed of two components: innate immunity and adaptive
immunity (Fig. 4) (Warrington et al., 2011). In order to recognize and subsequently
eliminate a pathogen, the host must have a strong and properly functioning immune
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system. The skin, which protects the host from pathogen infiltration, acts as a common
barrier and precedes the innate immune system (Warrington et al., 2011). In order to
function properly and efficiently, the host’s immune system must fulfill three
requirements: (1) recognize a wide, but diverse array of pathogens, (2) rid the host of
these pathogen once they are recognized by the immune system and (3) differentiate
between what is self and non-self (Beutler et al., 2004). Failure to accomplish these three
tasks or a defect in either branch of the immune system may lead to an autoimmune
disease, an immunodeficiency or a hypersensitivity (Warrington et al., 2011).

Fig. 4 Host immunity is composed of two components: innate immunity and
adaptive immunity. Innate immunity is the host’s first line of defense against
any infection. Adaptive immunity may take longer to activate, but it is highly
specific toward a particular pathogen (Townsend et al., 2008).
Whereas the innate immune system is present in all organisms, the adaptive
immune system is found exclusively in jawed fishes and upper vertebrates (Meeker and
Trede, 2008). Innate immunity, which is the first line of defense against any infection, is
non-specific and antigen-independent. Antigens are foreign molecules that may elicit an
immune response from the host (Warrington et al., 2011). An innate immune response
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can occur within minutes or even hours after the initial exposure and there is no
immunological memory to a particular antigen (Warrington et al., 2011). Adaptive
immunity, which is antigen-dependent and antigen-specific, is the second line of defense
against any infection (Warrington et al., 2011). Unlike its innate counterpart, adaptive
immunity is associated with immunological memory and takes longer to activate
(Warrington et al., 2011).
Adaptive immunity affords some advantages over its innate counterpart, but the
former also complements the latter. For example, antibodies produced by plasma B cells
(from the adaptive immune system) aid in opsonizing, or coating, bacteria for destruction
by innate immune cells (Warrington et al., 2011). Both components of the host’s immune
system depend upon certain immune cells to phagocytose, or engulf, the pathogen for
destruction (Warrington et al., 2011). Many of these immune cells arise from myeloid
progenitors, which include mononuclear and polymorphonuclear phagocytes (Beutler et
al., 2004). Mononuclear phagocytes include macrophages and dendritic cells, both of
which originate from monocytes (Beutler et al., 2004). Dendritic cells, which are highly
efficient at presenting antigens to T cells (from the adaptive immune system), play an
important role in both immune systems (Beutler et al., 2004). Polymorphonuclear
phagocytes include neutrophils, basophils, and eosinophils, all of which are vital in
containing infections (Beutler et al., 2004). To prevent pathogens from causing illness or
disease, the host must produce these immune cells and a variety of immune proteins, such
as interferon (IFN).
The ultimate goal of innate immunity is to recruit immune cells to sites of
infection or inflammation through production and distribution of certain proteins
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involved in cell-cell communication known as cytokines, including IFN (Warrington et
al., 2011). IFN production leads to the release of antibodies as well as other cytokines and
proteins, including those of the complement system (Warrington et al., 2011). Binding of
IFN to its receptor, the IFN receptor (IFNR), ultimately leads to the activation of IFNstimulated genes (ISG), which are critical to inducing the antiviral state (Garcia-Sastre
and Biron, 2006). The innate immune system is also crucial to ridding the body of
circulating dead cells (Beutler et al., 2004). Furthermore, activating the innate immune
system may lead to triggering its adaptive counterpart (Beutler et al., 2004).
Two of the key pathways of the innate immune system include the Toll-like
receptor (TLR) and the IFNR pathways (Fig. 5). TLRs are pattern recognition receptors
(PRR) that recognize conserved motifs known as pathogen-associated molecular patterns

Fig. 5 Two of the key pathways of antiviral innate immunity. Pathway 1, otherwise
known as the TLR pathway, functions in the initial recognition of the pathogen and is
critical to the production of IFN. Pathway 2, otherwise known as the IFNR pathway,
functions in the activation of genes necessary for inducing the antiviral state, including
IRF7 and Mx (Garcia-Sastre and Biron, 2006).
(PAMP) (Takeshita et al., 2004). The host is able to distinguish between what is self and
non-self by recognizing these PAMPs, which are only present in the pathogen (Ashkar
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and Rosenthal, 2002). Lipopolysaccharide (LPS) of Gram-negative bacteria is an
example of a bacterial PAMP (Blasius and Beutler, 2010). Some examples of viral
PAMPs include nucleic acids, such as dsRNA or unmethylated CpG DNA (Blasius and
Beutler, 2010). Recognition of PAMPs by PRRs results in downstream signaling, which
leads to the production of type I IFNs, other inflammatory cytokines, dendritic cell
maturation, and ultimately the establishment of the antiviral state (Kawai and Akira,
2006). Binding of IFN to the IFNR initiates the Janus-Kinase-Signal Transducer and
Activator of Transcription (JAK-STAT) signaling pathway, which is crucial for
transmitting information from the cell surface into the nucleus (Kawai and Akira, 2006).
As a result, antiviral genes, such as IFN regulatory factor 7 (IRF7) and Mx, that aid in the
induction of the antiviral state are activated (Kawai and Akira, 2006).

ANTIVIRAL EVASION
Viruses are intracellular pathogens that depend
upon the cell machinery of the host in order to replicate.
Therefore, the host’s immune system is critical to
combating any pathogen it may encounter, including
viruses. Induction of the antiviral state is a means by
which the host can block a viral infection (Fig. 6). By
halting RNA synthesis and protein synthesis, the host
Fig. 6 Induction of the antiviral cell can block viral replication (Kawai and Akira,
state involves downregulating
2006). But viruses have evolved ways to evade the
RNA synthesis and protein
synthesis to block viral
host’s antiviral immune response. One strategy
replication and thus prevent
further infection (Courtesy of
Kristin A. Gabor).
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employed by viruses is to modify specific cell membrane domains known as caveolae.
Previous studies have shown that interferon (IFN) receptors (IFNR) cluster within these
caveolae membrane domains (Gabor et al., Submitted). Upon viral infection, caveolin
transcripts are downregulated, caveolae membrane domains are modified, and clusters of
IFNRs are dispersed (Gabor et al., Submitted). As a result, downstream signaling is
dampened and the virus is able to evade the host’s antiviral innate immune response
(Gabor et al., Submitted).

TOLL-LIKE RECEPTOR (TLR) 9 (TLR9) PATHWAY
Organisms have evolved numerous defense mechanisms against a wide array of
microorganisms prevalent in the environment. One of the key players in the innate
immune system is the Toll-like receptor (TLR), a family of evolutionarily conserved,
germ-line-encoded pattern recognition receptors (PRR) (Akira and Takeda, 2004). The
host’s immune system must not only be able to recognize and eliminate various
pathogens, but perhaps more importantly, it must be able to distinguish between what is
self and non-self. This may be achieved through the recognition of conserved molecular
motifs commonly found in bacteria, viruses, fungi, and other microorganisms, known as
pathogen-associated molecular patterns (PAMP) (Takeshita et al., 2004). These PAMPs
are absent from the host and only present in the pathogen (Ashkar and Rosenthal, 2002).
The TLR pathway is thus crucial to facilitating antiviral signaling upon recognition of
viral PAMPs.
The Toll receptors, initially identified in Drosophila melanogaster, are vital to
embryological development of the insect as well as its innate immune response against
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fungal infection (Takeshita et al., 2004). Currently, eleven TLRs have been thoroughly
characterized in mammals, but more are being further studied (Takeshita et al., 2004).
Belonging to a family of PRRs, TLRs are type I membrane glycoproteins (Takeshita et
al., 2004). These membrane receptors may be positioned at the plasma membrane in the
case of TLR2 and TLR4 or intracellularly, at the endosomal membrane, in the case of
TLR3, TLR7 and TLR9 (Blasius and Beutler, 2010). Recent studies are focusing
primarily on the properties and functions of these intracellular receptors (Blasius and
Beutler, 2010). Each TLR differs from the
others on the basis of ligand specificity
and expression pattern (Ashkar and
Rosenthal, 2002).
TLRs consist of an extracellular
domain (ECD), consisting of fifteen
leucine-rich repeats (LRR), and a single
cysteine-rich domain (CRD); a
transmembrane domain (TMD); an
intracellular Toll/interleukin (IL)-1 receptor (TIR) domain; and approximately thirty-two
amino acids at the COOH-terminus that are crucial to the subsequent signal transduction
pathway (Fig. 7) (Takeshita et al., 2004).
Fig. 7 Structure of a Toll-like receptor (TLR).
The leucine-rich repeats (LRRs) functions in
the initial recognition of the pathogen. The
Toll/interleukin (IL)-1 receptor (TIR) domain
is crucial to the subsequent downstream
signaling cascade. TLRs are type I membrane
glycoproteins (Kuby et al., 2007).

The LRRs form a horseshoe structure that
is directly involved in the requisite
recognition of a pathogen (Akira and
Takeda, 2004).
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The function of TLRs is highly dependent upon their location within the cell.
TLRs located at the cell surface, such as TLR2 and TLR4, are recruited to phagosomes
after ligand binding and activation (Akira and Takeda, 2004). Intracellular TLRs, such as
TLR9, are initially expressed in the endoplasmic reticulum (ER), but are then recruited to
endolysosomes after stimulation with the appropriate ligand (Fig. 8) (Blasius and Beutler,
2010). The ligand for TLR9 is unmethylated CpG DNA (Blasius and Beutler, 2010;
Takeshita et al., 2004). The
acidic environment within
the endolysosomes is
crucial to the activation of
intracellular TLRs, since
compounds that prevent
acidification, such as
bafilomycin A1,
chloroquine and
ammonium chloride, seem
to abrogate their responses

Fig. 8 Processing of various intracellular TLRs. TLR9
is initially expressed in the endoplasmic reticulum (ER),
(Blasius and Beutler, 2010). translocates to the Golgi apparatus, and then is modified
in the endosome by cysteine proteases (Blasius and
Several chaperone proteins Beutler, 2010).
are required for proper and efficient translocation of intracellular TLRs from the
endoplasmic reticulum (ER) to the Golgi apparatus and subsequently endolysosomes
(Blasius and Beutler, 2010). Gp96, PRAT4A, and UNC93B1 are proteins that associate
with intracellular TLRs in the ER (Blasius and Beutler, 2010). Gp96 is an ER chaperone
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protein for TLRs, as well as immunoglobulin gamma (IgG), and certain integrins (Blasius
and Beutler, 2010). In macrophages lacking gp96, TLR9 cannot properly recognize or
respond to unmethylated CpG DNA (Blasius and Beutler, 2010). PRAT4A is required for
proper translocation of TLR1, TLR2, and TLR4 from the ER to the plasma membrane, as
well as TLR7 and TLR9 from the ER to the endosome, playing a critical role in the
functioning of most TLRs (Blasius and Beutler, 2010). UNC93B1, another ER protein,
also plays a vital role in mediating translocation of intracellular TLRs from the ER to the
endosomes (Blasius and Beutler, 2010).
Upon successful translocation from the ER, part of TLR9 is proteolytically
cleaved to yield the biologically active product, which is restricted to endosomes (Blasius
and Beutler, 2010). The full-length version of TLR is found exclusively in the ER
(Blasius and Beutler, 2010). Proteolytic cleavage of TLR9 is required for proper
recruitment of the adaptor molecule myeloid differentiation primary-response protein 88
(MyD88) and subsequent signal transductions, and has been shown to increase binding to
unmethylated CpG DNA (Blasius and Beutler, 2010).
CpG oligodeoxynucleotides (ODN) are synthetic DNA motifs that contain a
cytosine followed by a guanine and, depending on the particular CpG ODN, a
phosphodiester or phosphothioate DNA backbone (Ashkar and Rosenthal, 2002). CpG
ODNs are TLR-specific, stimulating and activating TLR9 only (Ashkar and Rosenthal,
2002). CpG sites are present in the genome of all organisms, but there are differences
among vertebrate and microbial CpG DNA (Ashkar and Rosenthal, 2002). In bacteria
genomes, CpG dinucleotides are found with a frequency of one in every sixteen
dinucleotides, whereas in vertebrates they are present at only one-fourth the expected
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frequency (Ashkar and Rosenthal, 2002). In vertebrates, CpG sites are commonly
preceded by a cytosine and followed by a guanine (Ashkar and Rosenthal, 2002). These
will not stimulate TLR9 nor elicit an immune response (Ashkar and Rosenthal, 2002). In
vertebrate DNA, approximately 70% of the cytosines are methylated, while CpG sites in
bacterial DNA are unmethylated (Ashkar and Rosenthal, 2002). Therefore, unmethylated
CpG DNA indicates to the host that a foreign pathogen is present (i.e. “non-self”)
(Ashkar and Rosenthal, 2002). Human embryonic kidney (HEK) 293 (HEK293) cells
transfected with mouse TLR9 (mTLR9) elicited the appropriate response upon exposure
to bacterial CpG DNA (Chuang et al., 2002). When exposed to other bacterial PAMPs or
control methlated CpG DNA, the
cells were unresponsive (Chuang
et al., 2002).
Upon stimulation of any
TLR with its appropriate ligand, a
signal transduction pathway is
initiated (Fig. 9). Unmethylated
CpG DNA is the ligand that
stimulates TLR9 specifically and
subsequently activates a signal
transduction pathway that is

Fig. 9 Intracellular TLR signaling pathway.
Upon activation of TLR9 by unmethylated CpG
DNA, a MyD88-dependent signal transduction
pathway is initiated. IRF7 is activated and type I
IFNs are produced (Garcia-Sastre and Biron,
2006).

dependent upon MyD88, which has
two protein interaction domains: an amino-terminal death domain and a carboxy-terminal
TIR domain (Ashkar and Rosenthal, 2002). Upon ligand binding, TLR9 receptor subunits
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dimerize, which results in the recruitment of MyD88 via the cytoplasmic TIRs of the
TLRs. (Ashkar and Rosenthal, 2002). Association of the TIR domain of MyD88 with the
TIR part of the TLRs facilitates association of the death domain of MyD88 with the IL1R-associated kinase (IRAK) and recruits IRAK to the receptor complex (Ashkar and
Rosenthal, 2002). Toll-interacting protein (TOLLIP) can also recruit IRAK to the same
complex (Ashkar and Rosenthal, 2002). IRAK is autophosphorylated upon reaching the
receptor complex and eventually dissociates to interact with tumor necrosis factor (TNF)receptor-associated factor 6 (TRAF6) (Ashkar and Rosenthal, 2002). TRAF6 induces
activation of transforming growth factor (TGF)-β activated kinase 1 (TAK1) and
mitogen-activated protein (MAP) kinase kinase 6 (MKK6), which subsequently activates
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), c-Jun N-terminal
kinases (JNK) and p38 (a class of MAP kinases), respectively (Ashkar and Rosenthal,
2002). TRAF6 also recruits ECSIT (evolutionary conserved signaling intermediate in toll
pathways) and activates activator protein (AP) 1 (AP-1) (a transcription factor) and NFκB (a protein complex that controls the transcription of DNA) (Ashkar and Rosenthal,
2002).
In addition, activation of TLR9 leads to the production of type I IFNs (Blasius
and Beutler, 2010). After binding of unmethylated CpG DNA to TLR9, and upon
complexing with MyD88, IFN regulatory factor 7 (IRF7) is phosphorylated by
interleukin-1 receptor-associated kinase 1 (IRAK1) and IRAK4, and translocates into the
nucleus (Kawai and Akira, 2006). Furthermore, IRF7 activation requires TRAF6 E3
ubiquitin ligase activity (Kawai and Akira, 2006). Activation of the TLR signaling
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pathway triggers the IFNR signaling pathway, which ultimately leads to the induction of
the antiviral state (Kawai and Akira, 2006).

INTERFERON (IFN) RECEPTOR (IFNR) PATHWAY
In order to respond to and prevent the propagation of pathogens, the host has
developed various defense mechanisms, including the production and secretion of
antimicrobial factors such as interferon (IFN), the first cytokine discovered (Samuel et
al., 2007). Previous studies found that chick cells infected with the influenza virus
produced and secreted a factor that seemed to facilitate and promote an antiviral state in
previously uninfected cells (Isaacs and Lindenmann, 1957). Due to “its ability to interfere
with virus growth,” the factor was referred to as IFN (Samuel et al., 2007).
There are three types of IFN, the first of which (type I) is important in facilitating
the antiviral state, with IFN-α and IFN-β as key players, but all IFNs are crucial to
regulating the immune system (Garcia-Sastre and Biron, 2006). Transcription factors,
such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), c-Jun Nterminal kinases (JNK), IFN regulatory factor 3 (IRF3) and IRF7, seem to regulate the
expression of type I IFNs (Kawai and Akira, 2006). In response to the host’s immune
system, pathogens have evolved countermeasures to dampen such defense mechanisms.
For example, by inhibiting the production of the above factors, viruses are able to inhibit
host cellular gene expression (Garcia-Sastre and Biron, 2006).
Induction of type I IFNs via TLR9 occurs via MyD88 (MyD88-dependent) in
association with the Toll/interleukin (IL)-1 receptor (TIR) domain of the TLRs,
interleukin-1 receptor-associated kinase 1 (IRAK1) and IRAK4, and tumor necrosis
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factor (TNF)-receptor-associated factor 6 (TRAF6) (Garcia-Sastre and Biron, 2006). As a
result, IRF7 is activated downstream, in addition to IκB kinase (IKK) α/β/γ and the
mitogen-activated protein kinases (MAPK) cascades, culminating in the activation of NFκB and activator protein (AP) 1 (AP-1) (Garcia-Sastre and Biron, 2006). Production of
IFN can also be triggered via other pathways independent of the membranous TLRs.
These cytoplasmic sensors include the retinoic acid-inducible gene I (RIG-I) and the
melanoma differentiation-associated gene 5 (Mda5) (Garcia-Sastre and Biron, 2006).
Regulation of type I IFNs occurs via the type I IFN receptor (IFNR), a cell surface
transmembrane receptor that is composed of two subunits: IFN-α receptor (IFNAR) 1
(IFNAR1) and IFNAR2 (Fig. 10) (Garcia-Sastre and Biron, 2006). Binding of IFN to the
IFNR results in the dimerization of
receptor subunits and subsequent
activation of kinases that associate
with their cytoplasmic tails: the
Janus-activated kinase 1 (JAK1) and
tyrosine kinase 2 (TYK2) (GarciaSastre and Biron, 2006). Next,
tyrosine phosphorylation activates
Fig. 10 After IFN is produced from the TLR
signaling pathway, it can bind to IFNRs on
neighboring cells to activate the IFNR signaling
pathway. This second pathway leads to the
activation of genes critical for the induction of the
antiviral state (Garcia-Sastre and Biron, 2006).

the signal transducers and activators
of transcription 1 (STAT1) and
STAT2 to form a trimeric STAT1STAT2-IRF9 complex, otherwise

known as IFN-stimulated gene factor 3 (ISGF3) (Garcia-Sastre and Biron, 2006). These
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complexes translocate to the nucleus and ultimately bind to DNA regulatory sequences
containing IFN-stimulated response elements (ISRE) (Garcia-Sastre and Biron, 2006). As
a result, hundreds of IFN-stimulated genes (ISG) are transcribed, and the antiviral state is
established (Garcia-Sastre and Biron, 2006).

CELL MEMBRANES
The previous fluid mosaic model posited that peripheral and integral proteins float
and diffuse throughout the plasma membrane (Singer and Nicolson, 1972). However, a
recent hypothesis proposes that proteins are distributed and clustered within membrane
domains known as lipid rafts (Fig. 11) (Cohen et al., 2004).

Fig. 11 Cell membrane domains known as lipid rafts are regions where receptors may be
clustered. This clustering may be vital for efficient signal transduction pathways
(Courtesy of Kristin A. Gabor).
These lipid rafts are rich in glycosphingolipids, sphingomyelin and cholesterol
(Chidlow and Sessa, 2010). Studies have implicated lipid rafts in the assembly and
budding of several enveloped viruses, such as influenza virus (Ravid et al., 2010).
Caveolae are morphologically distinct cell membrane domains with similar composition
to lipid rafts. These membrane domains are formed via the aggregation of sphingolipids
and sphingomyelin in the Golgi apparatus and then transported to the plasma membrane
(Cohen et al., 2004). The organization of lipid rafts and caveolae may play an important
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role in the function of membrane receptors as they are concentrated or segregated
(Chidlow and Sessa, 2010). Caveolae is of interest because it has been linked to various
signal transduction pathways, and ultimately, human disease processes, including breast
and prostate cancer, type II diabetes, and atherosclerosis (Cohen et al., 2004).

CAVEOLAE MEMBRANE DOMAINS
Caveolae are cell membrane domains that are similar to lipid rafts yet have a
unique morphology (Fig. 12) (Chidlow and Sessa, 2010). These structures are
characterized by their omega-like shape in the membrane and are approximately 50-100
nm in diameter (Cohen et al., 2004). Invagination of the plasma membrane occurs
through a largely unknown process (Cohen et al., 2004). In terms of tissues and cell
types, caveolae are ubiquitous and can be found in endothelial and epithelial cells,
adipocytes, and both striated and smooth muscle cells (Cohen et al., 2004). Their tissue
and cell type ubiquity make caveolae of particular interest for further research.

Fig. 12 Caveolae membrane domains. Caveolin-1 (shown in red) is a major structural
protein that directs signaling molecules to caveolae. Invagination of the plasma
membrane occurs through a largely unknown process (Courtesy of Kristin A. Gabor).
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Caveolae are further distinguished from lipid rafts by the presence of the
caveolin-1 (Cav-1) protein (~22 kDa) (Cohen et al., 2004). Cav-1 is a major structural
component and functions as a scaffolding protein that directs signaling molecules to
caveolae (Gadjeva et al., 2010). Clathrin-independent endocytosis and regulation of
intracellular signaling pathways are two processes that depend upon caveolae and
caveolin (Ravid et al., 2010).
Cav-1 belongs to the caveolin gene family, along with cav-2 and cav-3, all of
which encode 20-24 kDa proteins (Ravid et al., 2010). Cav-1 has been shown to interact
directly with Cav-2 in the endoplasmic reticulum (ER) to form hetero-oligomeric
complexes that target lipid rafts and drive the formation of caveolae membrane domains
(Ravid et al., 2010). Cav-1 homo-oligomerizes into structures of ~400 kDa (Gadjeva et
al., 2010). Little is known about Cav-2 except that it is co-expressed and dependent upon
Cav-1, and is alone insufficient to induce caveolae biogenesis (Cohen et al., 2004). By
forming hetero-oligomeric complexes with Cav-1, Cav-2 has been suggested to play a
vital role in proper caveolae membrane domain assembly (Chidlow and Sessa, 2010). In
addition, Cav-2 may regulate the number of caveolae membrane domains (Chidlow and
Sessa, 2010). Unlike Cav-1 and Cav-2, which are expressed nearly ubiquitously, Cav-3 is
specific to muscle cells (Cohen et al., 2004).
The importance of caveolae can be illustrated through cav knockout experiments.
For example, knockout of cav-1 expression results in the loss of caveolar structures
(Cohen et al., 2004). While mice deficient in caveolin may be viable, knockout of Cav-1,
Cav-2, or Cav-3 leads to different phenotypes (Gadjeva et al., 2010). In contrast,
knockout of Cav-1 in the zebrafish leads to developmental abnormalities and even death
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(Frank and Lisanti, 2006). For example, it has been shown that knockdown of Cav-1 in
zebrafish leads to the disruption of neuromast maturation (Nixon et al., 2007). Depletion
of caveolin leads to noticeable and dramatic defects in neural and eye development and
organogenesis (Fang et al., 2006); recent studies have produced similar results (Nixon et
al., 2007). Interestingly, exogenous expression of cav-1 will induce formation of caveolae
in cells lacking both caveolae and Cav-1 (Gadjeva et al., 2010). Furthermore, Cav-1 has
two isoforms, but previous studies have shown that Cav-1a and Cav-1b have nonredundant roles in the zebrafish (Fang et al., 2006). The role of Cav-1 during the immune
response to viral infection is largely unexplored.

GENETIC MANIPULATION USING MORPHOLINO OLIGONUCLEOTIDES
(MO)
Genetic manipulation is an important cornerstone of research in the realm of
genetics and developmental biology. Reverse genetics allows for the study of the normal
biological function of a gene by manipulating the action of that gene of interest during
development (Eisen and Smith, 2008). On the other hand, forward genetics is concerned
with the study of a particular phenotype and determining the genetic basis for that
phenotype (Lieschke and Currie, 2007).
The most widely used reverse genetics antisense technique employed for gene
knockdown in the zebrafish are morpholino oligonucleotides (MO). Developed by Dr.
James Summerton, MOs (antisense) were first targeted to inhibit translation of mRNA
(sense) in vivo (Bill et al., 2009). Similar to DNA and RNA oligomers, MOs are
composed of 25 morpholine bases [O(CH2CH2)2NH] (Bill et al., 2009). More
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importantly, MOs are capable of undergoing Watson-Crick base pairing (Eisen and
Smith, 2008). A neutrally charged phosphorodiamidate backbone gives rise to a high
binding affinity for RNA and aids in steric hindrance (Bill et al., 2009). Unlike DNA and
RNA, MOs do not carry an overall negative charge, making them less likely to interact
non-specifically with other cellular components (Eisen and Smith, 2008). As a result,
MOs are resistant to nucleases and are thus stable (Eisen and Smith, 2008).
There are two types of MOs: splice blocking and translational blocking (Fig. 11).
Splice blocking MOs inhibit components of the spliceosome, a protein complex that
removes introns from pre-mRNA (Bill et al., 2009). Translational blocking MOs bind to
complementary mRNA sequences and prevent proper assembly of the ribosomal complex
(Bill et al., 2009). Certain assays could be performed to quantify the efficiency of MO
knockdown, such as reverse transcription polymerase chain reaction (RT-PCR) in the
case of splice blocking MOs or a western blot in the case of translational blocking MOs.
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Fig. 13 Gene knockdown technique utilizing MOs. (A) Structure of a MO, which shares
similarities to DNA and RNA oligomers. (B, C, D) Splice blocking MO mechanism. (E,
F) Translational blocking MO mechanism (Bill et al., 2009).

Both splice blocking and translational blocking MOs inhibit zygotic transcripts,
but the latter can inhibit maternal transcripts as well (Bill et al., 2009). Typically, MOs
are introduced into 1-8-cell-staged zebrafish embryos, but my experiments are focused on
the 1–2-cell stage (Bill et al., 2009). This allows for the rapid diffusion of MOs through
the early embryonic cells, resulting in ubiquitous delivery.
Since MOs are fairly new genetic manipulation techniques, there are some
important matters to keep in mind. An important concern when employing MOs is the
control. Perhaps the most reliable control in any MO experiment is to attempt to “rescue”
the phenotype by introducing the gene product of interest in a form that is unaffected by
the MO (Eisen and Smith, 2008). A common rescue technique is to inject mRNA at the
1-cell stage (Eisen and Smith, 2008). When employing a translational blocking MO,
removing the 5’ untranslated region (UTR) of the mRNA or introducing silent mutations
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into the coding region should rescue the phenotype (Eisen and Smith, 2008). Simply
injecting mRNA when employing a splice-blocking MO should rescue the phenotype as
well (Eisen and Smith, 2008).
The efficacy of MO knockdown varies with each MO since they are sequence
specific, so the amount and duration of knockdown is variable (Bill et al., 2009). Thus,
MO knockdowns and other genetic manipulation techniques have allowed the discovery
of certain genes in screens, the identification of gene function, and the verification of
certain mutant phenotypes (Bill et al., 2009).

FLUORESCENCE PHOTOACTIVATION LOCALIZATION MICROSCOPY
(FPALM)
With the advent of light microscopes came important biological discoveries, but
the laws of diffraction limit the resolution of light microscopy techniques. Diffraction is
the scattering of light, and molecules that are close together appear blurred as a result of
this property (Gabor et al., 2011). With light microscopes, many molecules are visible at
a given time, leading to blurred images. In the 19th century, Ernst Abbe determined that
the smallest features that could be imaged in a light microscope are about 200-250 nm for
visible light (Hess et al., 2009). But much of science, especially biology, occurs at
cellular and molecular levels. Electron microscopy allows for imaging on a smaller, more
relevant scale, but living specimens cannot be imaged. This prompted the search for an
alternative microscopy technique (Fig. 14).
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Fig. 14 (A) Conventional confocal image of a fibroblast cell. (B) FPALM image of a
fibroblast cell (Hess et al., 2007).

To improve resolution, localization (determination of position) microscopy
combines the physics of light with the imaging of single molecules through
photoactivatable and photoswitchable fluorescent proteins or probes (PAFP) (Hess et al.,
2009). PAFPs differ from conventional fluorescent probes in being non-fluorescent or
inactive in the sample being imaged until they are photoactivated by a certain wavelength
of light (Gould et al., 2009).
Localization microscopy circumvents the diffraction limit set by the Rayleigh
criterion (R0=0.61λ/NA, where λ is the wavelength of detected light and NA is the
numerical aperture) by not visualizing all molecules at once (Gould et al., 2009).
According to the Rayleigh criterion, objects that are closer together than this given
distance (~200-250 nm) are unresolved. By imaging a small subset of molecules
separately, each molecule can be distinguished from the others (Fig. 15) (Hess et al.,
2009). These subsets are activated randomly by illuminating the sample with a
wavelength of light (activation laser) that is able to switch the PAFPs from inactive or
invisible into an active or visible state. Using a second wavelength of light (readout
laser), the activated molecules can be excited, resulting in the emission of fluorescence,
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which can be imaged by a high-sensitivity camera. The position of each fluoresced
molecule can then be determined, or localized. For a short period of time, the molecules
remain visible, but photobleach, or lose fluorescence, under the high-intensity
illumination (Hess et al., 2009). These repeated cycles of activation, imaging, localization
and photobleaching allow for the collection of data consisting of thousands of molecules
and the ultimate generation of an image. Once the molecules have been localized, these
positions can be plotted and compiled to obtain the desired image (Hess et al., 2009).
Utilizing these PAFPs and adjusting the rates of photoactivation and photobleaching
allow the user direct optical control over the number of fluorescent molecules at a given
time (Gabor et al., 2011). The activation laser is used to control the density of visible
molecules so that individual molecules can be identified and localized, while the readout
laser is used to collect the fluorescence from the activated molecules (Gabor et al., 2011).
Three localization microscopy methods were introduced in 2006—Fluorescence
Photoactivation Localization Microscopy (FPALM) (Hess et al., 2006), Photoactivated
Localization Microscopy (PALM) (Betzig et al., 2006) and Stochastic Optical
Reconstruction Microscopy (STORM) (Rust et al., 2006). These microscopy techniques
now allow for imaging in living cells and for imaging multiple-probe-labeled species as
well as three-dimensional samples (Hess et al., 2009). The probes in each of these
microscopy techniques allow for the control of the number of fluorescent molecules
visible at a single time by adjusting the rates of photoactivation and photobleaching
(Gabor et al., 2011). The length-scale of resolution with features smaller than 200-250
nm can be achieved with localization microscopy by about tenfold, with FPALM
achieving approximately 20-30 nm lateral resolution.
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Although these techniques have contributed a great deal to improving resolution
in the realm of microscopy, there still remain limitations, such as the shortage of suitable
PAFPs. For example, PAFPs need to be invisible before they can be activated. Upon
activation by the appropriate laser, a large number of photons must be emitted over a
short amount of time. In order to be read as single molecules, the photons need to be
quickly imaged. These restrictions limit the supply of suitable PAFPs (Hess et al., 2009).
Also, the number of genetically encoded PAFPs is small compared to that for standard
fluorescence imaging (Hess et al., 2009). Another important limitation is the tradeoff
between spatial and temporal resolution. Minimization of background is crucial both for
identification of fluorescent probe molecules, and for maximization of the localization
precision (Hess et al., 2009).
FPALM and related super-resolution localization microscopy techniques will
continue to offer advantages over conventional light microscopy, and will prompt interest
for further research. Although there still remain limitations, FPALM offers a novel
alternative to conventional light and electron microscopy techniques. Just as with
conventional light microscopes, the advent of FPALM will offer many important
biological discoveries.

PREVIOUS STUDIES
Previous studies have shown that knockdown (KD) of caveolin-1 (Cav-1)
transcripts led to a dampened antiviral response (Gabor et al., Submitted). A microarray
was performed to examine the global gene regulation of the zebrafish upon infection with
snakehead rhabdovirus (SHRV). Cell membrane proteins were of interest because Toll-

31
like receptors (TLR) and interferon (IFN) receptors (IFNR) are membranous receptors.
Data from the microarray revealed that caveolin-1 (Cav-1) is downregulated upon viral
infection, and is thus a molecule of interest.
Infection with SHRV, a genus of the family Rhabdoviridae, leads to a dampening
in overall IFN activity, as a result of caveolin depletion and thus disruption of caveolae
membrane domains. Further studies show that caveolae play an important role in the
clustering of IFNR molecules to ensure proper signaling responses. Whole virus
infections have been shown to alter Cav-1 clustering and dampen downstream IFNR
signaling. Since there was a dampening in overall IFN activity, I hypothesize that
caveolae may also have an upstream function in TLR signaling, playing a similar role in
the clustering of TLRs to maintain efficient signal transductions.

MATERIALS AND METHODS
Cell culture, constructs and transfections.
Cell Culture. Zebrafish liver (ZFL) cells were maintained at 28°C, 0% CO2 in leukocyte
depletion filter (LDF) cell culture medium (50% Leibovitz’s L-15, 35% Dulbecco’s
modified Eagle’s, and 15% F-12) supplemented with heat-inactivated fetal bovine serum.
Constructs. pcDNA3.1 TLR9 and pcDNA3.1 Cav-1b constructs were isolated via an
Endotoxin-Free Plasmid Isolation Miniprep Kit (Omega). Plasmids were linearized to
allow for the insertion of the photoactivatable fluorescent probes (PAFP). The restriction
enzymes KpnI and EcoRV linearized TLR9 to allow for the insertion of dendra2. The
restriction enzymes KpnI and EcoRI linearized Cav-1b to allow for the insertion of PAmCherry.
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Nucleofection for Imaging. Zebrafish liver (ZFL) cells were grown to approximately 80%
confluency and then washed with phosphate buffered saline (PBS). The cells were
subsequently trypsinized and re-suspended in leukocyte depletion filter (LDF) cell culture
medium before being concentrated via centrifugation at 90xg for 10 min. The supernatant
was removed and the cell pellet was re-suspended in Cell Line 96-well Nucleofector
Solution (Lonza). A total of 250 ng of DNA for each of the constructs of TLR9 and Cav1b were added to 1.6x107 cells in 20 μl/well in a 96-well transfection module (Lonza).
Cells were electroporated using the Nucleofector 96-well Shuttle System (Lonza) and
allowed to recover for 10 min at room temperature before resuspension in 80 μl of LDF
media. Transfected cells (20 μl/construct) were then plated into 96-well plates containing
180 μl of LDF media. Cells were maintained for 24 hr at 28°C before imaging.
Nucleofection for Assaying. For Dual-Luciferase Reporter Assay, zebrafish liver (ZFL)
cells were grown to approximately 80% confluency and then washed with phosphate
buffered saline (PBS). The cells were subsequently trypsinized and re-suspended in
leukocyte depletion filter (LDF) cell culture medium before being concentrated via
centrifugation at 90xg for 10 min. The supernatant was removed and the cell pellet was
re-suspended in Cell Line 96-well Nucleofector Solution (Lonza). A total of 250 ng of
DNA for each of the constructs (TLR9 and Cav-1b), 250 ng of IFN-luc, and 6.25 ng of
pRL-CMV were added to 1.6x107 cells in 20 μl/well in a 96-well transfection module
(Lonza). Cells were electroporated using the Nucleofector 96-well Shuttle System
(Lonza) and allowed to recover for 10 min at room temperature before resuspension in
180 μl of LDF media. Cells were plated in triplicate in a 96-well plate. Cells were
maintained for 24 hr at 28°C before assaying.
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Morpholino Oligonucleotide (MO) Knockdown.
Cav-1b MO. In order to access the extent of IFN induction via TLR9 as a result of
caveolin depletion, a Cav-1b MO must be employed. A control MO was also utilized to
ensure that the effects of IFN induction were a result of Cav-1b knockdown only and not
a result of the MO being transfected. A previously characterized Cav-1b MO was used as
described by (Fang et al., 2006), and co-transfected with TLR9 construct (Amaxa).
Dual-Luciferase Reporter Assay.
Cells were transfected as described above and maintained for 24 hr at 28°C before
assaying. Subsequently, cells were exposed to CpG 1668 at 1 μM for 8 hr. Following
exposure, cells were gently washed with 100 μl Dulbecco’s phosphate buffered saline
(PBS). Rinse solution was removed before applying 1x Passive Lysis Buffer (PLB). PLB
(40 μl) was added to zebrafish liver (ZFL) cells before the 96-well plate was placed on a
Gyrotory Shaker (Model G-2) for 15 min at 150 rpm. After the allotted time, the cell
monolayer was disrupted by gently scraping the bottom of the wells. Cell lysate (20 μl)
was added to a white half-volume 96-well plate. Firefly and Renilla luciferase activity
was measured using the Dual-Luciferase Reporter Assay system (Promega). Relative
luminescence units (RLU) were measured in a GLOMAX luminometer (Promega).
Single-Molecule Microscopy.
Single-color FPALM imaging and analysis. Single-color FPALM imaging was performed
as described by (Gould et al., 2009; Hess et al., 2009). Two lasers at different
wavelengths were used for activation (405 nm) and readout (556 nm). Cells were selected
for FPALM imaging by searching for green fluorescence (TLR9-dendra2). Analysis was
performed using custom software (Matlab).
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Two-color FPALM imaging and analysis. Two-color FPALM imaging was performed as
described by (Gunewardene et al., 2011). Two lasers at different wavelengths were used
for activation (405 nm) and readout (556 nm). Cells were selected for FPALM imaging
by searching for green fluorescence (TLR9-dendra2) and red fluorescence (Cav-1b-PAmCherry). Analysis was performed using custom software (Matlab).
Pair correlation calculations. Pair correlation calculations of single-color and two-color
FPALM were performed using custom software (Matlab). The g(r) value estimates the
density at a distance r from a given molecule and compares it to a random distribution. A
g(r) value equal to one indicates a sample with uniform distribution. A g(r) value greater
than one indicates dense regions of clustering. A g(r) value less than one indicates a declustered sample. This g(r) value allows for the quantification of clustering that may be
observed in a given sample.

RESULTS
TLR9 has two caveolin-binding motifs. Most caveolae-associated proteins contain a
certain caveolin-binding motif. Upon isolation via an Endotoxin-Free Plasmid Isolation
Miniprep Kit (Omega), samples of TLR9 were sent for genomic sequencing. After
analysis, two related caveolin-binding motifs (ΦXΦXXXXΦ and ΦXXXXΦXXΦ, where
Φ is aromatic amino acid Trp, Phe, or Tyr) were elucidated for TLR9 (Fig. 15). One of
these caveolin-binding motifs (FYFSMWHF) resides between two LRR domains in the
TLR9 transcript. The other motif (FLFPKFKY) resides in the TIR domain of TLR9. It is
also known from in vitro studies that aromatic residues (Trp, Phe, or Tyr) are required for
the proper recognition of the caveolin-binding motif. This would suggest a role for
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caveolin in the TLR9 signaling pathway.

Fig. 15 Amino acid sequence of TLR9. TLR9 has two caveolin-binding motifs. The
sequences highlighted in yellow are the caveolin-binding motifs that were elucidated
upon analysis of the amino acid sequence of TLR9.

Rab7 colocalizes with TLR9 in the zebrafish. To test whether TLR9 was located
intracellularly in the endosomes, zebrafish liver (ZFL) cells were co-transfected with
Rab7-PA-Cherry and TLR9-dendra2. Rab7 is a late endosomal marker protein. (Fig. 16)
are confocal images of ZFL cells fixed in 3.6% paraformaldehyde 24 hr post-transfection.
These genetic PAFPs were utilized to test whether TLR9 would still localize properly, as
the same constructs were employed for single-color and two-color FPALM experiments.
Regions of yellow indicate spatial overlap, or colocalization, of Rab7 and TLR9
molecules. This confirms that TLR9 is indeed located in the endosome of zebrafish.
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Fig. 16 Confocal images of ZFL cells co-transfected with Rab7, a late endosomal
marker protein, and TLR9. (A) Regions of yellow indicate spatial overlap, or
colocalization, of Rab7 and TLR9 molecules. (B) TLR9-dendra2 molecules. (C)
Rab7-PA-mCherry molecules. (D) Bright-field view of ZFL cells, confirming
colocalization of Rab7 and TLR9 in the endosome of zebrafish. Scale bar: 20 μm.
TLR9 clusters in the endosome of zebrafish. After confirming that TLR9 is located in
the endosome, the next step was to determine whether TLR9 forms clusters in the
endosome using FPALM imaging. By overexpressing TLR9 in zebrafish liver (ZFL)
cells, clusters of TLR9-dendra2 molecules (shown in white boxes) could be seen through
single-color FPALM imaging (Fig. 17). There are 1573 molecules present. Pair
correlation analysis generated a g(r) value of 2.4, indicating that molecules are clustered.
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Fig. 17 TLR9 clusters in the endosome of zebrafish. Single-color FPALM image of
TLR9-dendra2 overexpressed in ZFL cells. Clustering of TLR9 molecules is apparent
(shown in white boxes). Statistical analysis generated a g(r) value of 2.4, indicating that
molecules are not randomly distributed, and instead are clustered. Scale bar: 1 μm.
TLR9 and caveolin colocalize in the endosome of zebrafish. Upon confirming that
TLR9 is localized in the endosome and that TLR9 clusters, colocalization between TLR9
and caveolin (shown in white boxes) was demonstrated. By performing two-color
FPALM imaging, clusters of TLR9-dendra2 and Cav-1-PA-mCherry could be seen (Fig.
18). This would suggest a role for caveolin in the TLR9 signaling pathway. Pair
correlation analysis generated a g(r) value of 1.6, indicating that molecules are clustered
and colocalize.
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Fig. 18 TLR9 and caveolin colocalize in the endosome of zebrafish. Two-color FPALM
image of ZFL cells overexpressing TLR9-dendra2 and Cav-1-PA-mCherry. Regions of
yellow indicate colocalization of TLR9 and Cav-1 molecules (shown in white boxes).
Statistical analysis generated a g(r) value of 1.6, indicating that molecules are not
randomly distributed, and instead are clustered and colocalize. Scale bar: 1 μm.
Induction of IFN is dampened as a result of depleting caveolin. Since TLR9 and
caveolin colocalize in the endosome of zebrafish, the effect of depleting caveolin on IFN
induction via TLR9 was ascertained by performing a Dual-Luciferase Reporter Assay in
ZFL cells overexpressing TLR9. Through the luciferase assay, induction of IFN promoter
activity was quantified. By stimulating TLR9 with the target ligand CpG 1668 at 1 μM,
IFN promoter activity could be induced. Compared to control ZFL cells, the extent of
IFN activity in caveolin-depleted ZFL cells is dampened (Fig. 19). p<0.01.
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Fig. 19 Induction of IFN is dampened as a result of depleting Cav-1. Dual-Luciferase
Reporter Assay was performed with the IFN promoter as the gene of interest so IFN
activity could be quantified. TLR9 was stimulated with CpG 1668 at 1 μM. Compared to
control ZFL cells, the extent of IFN activity in caveolin-depleted ZFL cells is dampened.
p<0.01.

DISCUSSION
Viruses are prevalent throughout the world and can cause numerous diseases and
illnesses. Our lab is interested in innate immunity and related signal transduction
pathways. Employing the zebrafish as a model for human infectious diseases and
understanding how pathogens are able to circumvent the host’s immune system will aid
in developing new and effective treatments against infections. But in the present study, I
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focus attention on zebrafish liver (ZFL) cells. These are initial experiments and these
processes need to be examined in vitro in cell culture before they can be studied in vivo.
Previous studies show that upon viral infection, caveolin transcripts are
downregulated, caveolae membrane domains are disrupted, and thus clusters of IFN
receptors are dispersed (Gabor et al., Submitted). As a result, downstream signaling of
the IFNR pathway is abrogated and host antiviral immune response is dampened. I want
to identify a role for caveolin upstream of this pathway in the TLR signaling pathway and
determine whether caveolae are vital for TLR9 clustering and subsequent downstream
signaling.
The amino acid sequence of antiviral toll-like receptors TLR3, TLR7, and TLR9
were analyzed for caveolin-binding motifs. Out of these TLRs, only TLR9 contained a
caveolin-binding motif, which is present in most caveolae-associated proteins. The
sequences ΦXΦXXXXΦ and ΦXXXXΦXXΦ (Φ = Trp, Phe, or Tyr) are present in these
proteins. I discovered two caveolin-binding motifs in TLR9 transcripts, FYFSMWHF and
FLFPKFKY (Fig. 15). One of these caveolin-binding motifs (FYFSMWHF) resides
between two LRR domains in the TLR9 transcript. This caveolin-binding motif may play
a critical role in proper ligand recognition, as the leucine-rich repeats (LRR) of the TLR
is necessary for pathogen recognition. The other motif (FLFPKFKY) resides in the TIR
domain of TLR9. This caveolin-binding motif may play a vital role in the association of
the TIR domains of MyD88 and TLR9 and the initiation of signal transductions.
Aromatic residues are vital for proper recognition of the caveolin-binding motif. Since
TLR9 has these two caveolin-binding motifs, I suspect that TLR9 interacts with caveolin.
Thus, caveolae may be vital for TLR9 signaling. Viral modulation of caveolae may
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therefore be a two-pronged approach for evasion of IFN production. This hypothetical
interaction is what led me to the present study, predicting a role for caveolin in the TLR9
pathway. Interestingly in the zebrafish, the amino acid sequence for CRFB1, a
component of the IFNR complex, also possesses a caveolin-binding motif (Gabor et al.,
Submitted).
Since TLR9 is an endosomal receptor, it was of interest to determine the location
of TLR9. After overexpressing Rab7-PA-mCherry and TLR9-dendra2 in ZFL cells,
confocal images illustrated colocalization of these two molecules (Fig. 16). Since TLR9dendra2 is located in the endosome, it could be demonstrated through single-color and
two-color FPALM imaging that TLR9 molecules were present in the endosome. In the
FPALM images, each green dot represents a single TLR9 molecule (Fig. 17). Singlecolor of TLR9-dendra2 only and two-color FPALM of TLR-dendra2 co-transfected with
Cav-1b-PA-mCherry permits visualization of TLR9, either in clusters or randomly
distributed in the endosome. In this way, it is possible to ascertain visually whether TLR9
forms clusters and colocalizes with caveolin.
In order for TLR9 to signal efficiently, clustering of these receptors in the
endosome is necessary. I want to investigate the role of caveolin in the clustering and
function of these receptors. Single-color FPALM of TLR9-dendra2 overexpressed in ZFL
cells without ligand stimulation illustrated such clustering. Of the 1573 single molecules
of TLR9 imaged (Fig. 17), pair correlation statistical analysis generated a g(r) value of
2.4, which means that the TLR9 molecules were not randomly distributed, and instead
were clustered. If TLR9 receptors were not clustered within caveolae membrane
domains, there would not have been efficient downstream signaling from this pathway.
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The concentration of TLR9 into clusters is due to the organization of these caveolae
membrane domains. TLR9 forms clusters in the endosome without ligand stimulation and
these clusters should be dispersed during viral infection. I hypothesize that viruses are not
only able to disrupt caveolae membrane domains at the cellular membrane, where the
IFNRs are positioned and clustered (Gabor et al., Submitted), but also at the endosomal
membrane, where the TLR9 receptors are positioned and clustered.
Since TLR9 transcripts contain two caveolin-binding motifs, it is possible that
caveolae are critical for TLR9 signaling. After confirming that TLR9 clusters in the
endosome, I want to determine whether caveolin and TLR9 indeed colocalize. Through
two-color FPALM imaging, colocalization of the two species, shown as regions of yellow
(Fig. 18), is demonstrated. It has not been shown previously that TLR9 and caveolin
colocalize in the endosome of zebrafish. This finding implies that TLR9 and caveolin are
interacting in the endosome. If caveolin is downregulated, caveolae membrane domains
are disrupted and clusters of TLR9 are dispersed. As a result, downstream signaling of
the TLR9 pathway is dampened. This suggests a role for caveolae, not only in the IFNR
pathway, but the TLR pathway as well. Thus, viruses may be circumventing two
important antiviral innate immune responses.
Since colocalization of TLR9 and caveolin had now been shown, the next step
was to study the effects of depleting caveolin on TLR9 signaling. Upon activation of
TLR9 with unmethylated CpG DNA (i.e., CpG 1668), the TLR signaling pathway is
initiated (Fig. 9), and IFN expression is induced. IFN is secreted and binds to the IFNR
on neighboring cells, initiating a second signal transduction pathway (Fig. 10). This
pathway ultimately leads to the activation of antiviral genes vital for inducing the
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antiviral state. In this antiviral state, virus replication is blocked (Fig. 6). Even so, viruses
have evolved ways to evade such host antiviral immune response. Our lab has shown
previously that viruses modulate caveolae, leading to the disruption of IFNR clusters
(Gabor et al., Submitted). The aim of the present study is to examine how modulating
caveolae affects clusters of TLR9. The extent of IFN induction was quantified via a DualLuciferase Reporter Assay (Fig. 19). The value of relative luminescence units (RLU) is
directly related to the level of IFN activity. The control ZFL cells illustrate how TLR9
would normally respond to unmethylated CpG DNA in cells with normal expression of
caveolin and thus intact caveolae membrane domains. When stimulated by the
appropriate ligand, IFN is induced significantly, but in Cav-1b depleted ZFL cells, the
level of IFN induction from ligand stimulation was not significantly induced, and it is
instead comparable to unexposed ZFL cells. I demonstrated that TLR9 forms clusters and
colocalizes with caveolin so I can postulate that caveolae are needed to maintain TLR9
clusters. This suggests a role for caveolae in clustering TLR9 receptors for IFN induction
through the TLR9 signaling pathway.
In this study, I demonstrate that TLR9 and caveolin colocalize in the endosome. I
show that as a result of depleting caveolin, IFN expression via TLR9 is dampened upon
ligand stimulation, suggesting a role for caveolin in the TLR9 signaling pathway.
Since it has now been shown that TLR9 and caveolin colocalize and I have also
demonstrated that caveolae are vital for TLR9 signaling, I hypothesize that fewer TLR9
molecules will be observed by FPALM if Cav-1 is depleted, and that the clusters of
TLR9 molecules will be dispersed.
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Having elucidated two caveolin-binding motifs for TLR9, I anticipate the
discovery of the protein-protein interactions between TLR9 and Cav-1 using biochemical
techniques. Western blot analysis will determine if this interaction indeed exists and sitespecific mutagenesis of the caveolin-binding motif in TLR9 transcripts, western blot
and/or FPALM imaging can report whether the two proteins no longer interact or
colocalize.
The majority of experiments discussed up to this point have been performed in
vitro in ZFL cells. It will be interesting to explore these same processes in vivo in the
zebrafish by depleting TLR9 with a TLR9 MO, followed by exposure to unmethylated
CpG DNA or live bacteria such as Pseudomonas aeruginosa or Edwardsiella tarda.
In conclusion, previous studies show that upon viral infection, caveolin transcripts
are downregulated, clusters of IFNRs are dispersed, and antiviral immune responses are
abrogated (Gabor et al., Submitted). I want to understand further the role of caveolin
upstream in the TLR signaling pathway. Our lab has demonstrated that upon viral
infection or ligand exposure, depletion of caveolin and the disruption of caveolae
membrane domains leads to dampened IFN production in addition to dispersed IFNRs
(Gabor et al., Submitted) and possibly TLRs. Thus, viruses are evading not just one, but
two important host antiviral innate immune responses. Understanding the mechanisms by
which viruses are evading the host’s immune system will prove to be important in the
study and the development of new and effective targeted treatments, such as IFN and
TLR antiviral therapies.
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